C57BL/6 NK cell gene complex is crucially involved in vascular remodeling

Journal of Molecular and Cellular Cardiology

Volumn 64, Issue , 2013, Pages 51-58

  de Vries, M R ^a   Seghers, L ^a,b   van Bergen, J ^a   Peters, H A B ^a   de Jong, R C M ^a   Hamming, J F ^a   Toes, R E M ^a   van Hinsbergh, V W M ^b   Quax, P H A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; IFN ; Intimal hyperplasia; NK cell gene complex; NK cells; Vascular remodeling

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALB/C NUDE MOUSE; C57BL 6 MOUSE; CELL INFILTRATION; CMV1 MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMORAL ARTERY; GENE LOCUS; LYMPHOCYTE DEPLETION; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NK CELL GENE COMPLEX; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VASCULAR DISEASE; VASCULAR REMODELING; VEIN GRAFT;

MUS;

CARDIOVASCULAR DISEASE; IFN-Γ; INTIMAL HYPERPLASIA; NK CELL GENE COMPLEX; NK CELLS; VASCULAR REMODELING;

ANIMALS; ARTERIES; BLOOD VESSELS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERPLASIA; INFLAMMATION; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; TUNICA INTIMA; VEINS;

EID: 84884516589     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.08.009     Document Type: Article

References (37)

1. Gibbons G.H., Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 1994, 330:1431-1438.
2. van Weel V., Toes R.E., Seghers L., Deckers M.M., de Vries M.R., Eilers P.H., et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 2007, 27:2310-2318.
3. Gibbons G.H. The pathogenesis of graft vascular disease: implications of vascular remodeling. J Heart Lung Transplant 1995, 14:S149-S158.
4. Pasterkamp G., de Kleijn D.P., Borst C. Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res 2000, 45:843-852.
5. Rosenblum W.D. Pulmonary arterial hypertension: pathobiology, diagnosis, treatment, and emerging therapies. Cardiol Rev 2010, 18:58-63.
6. Robson A., Harris L.K., Innes B.A., Lash G.E., Aljunaidy M.M., Aplin J.D., et al. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 2012, 26:4876-4885.
7. Trowsdale J., Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008, 20:317-320.
8. Bryceson Y.T., Chiang S.C., Darmanin S., Fauriat C., Schlums H., Theorell J., et al. Molecular mechanisms of natural killer cell activation. J Innate Immun 2011, 3:216-226.
9. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008, 28:1950-1959.
10. Whitman S.C., Rateri D.L., Szilvassy S.J., Yokoyama W., Daugherty A. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler Thromb Vasc Biol 2004, 24:1049-1054.
11. Ormiston M.L., Chang C., Long L.L., Soon E., Jones D., Machado R., et al. Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension. Circulation 2012, 126:1099-1109.
12. Feuchtner G.M., Cury R.C., Jodocy D., Friedrich G.J., Blumenthal R.S., Budoff M.J., et al. Differences in coronary plaque composition by noninvasive computed tomography angiography in individuals with and without obstructive coronary artery disease. Atherosclerosis 2011, 215:90-95.
13. Hansen J.F. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989, 117:290-295.
14. Harmon K.J., Couper L.L., Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 2000, 156:1741-1748.
15. Chalothorn D., Clayton J.A., Zhang H., Pomp D., Faber J.E. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics 2007, 30:179-191.
16. Helisch A., Wagner S., Khan N., Drinane M., Wolfram S., Heil M., et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 2006, 26:520-526.
17. Schulte S., Sukhova G.K., Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am J Pathol 2008, 172:1500-1508.
18. Ryan J.C., Naper C., Hayashi S., Daws M.R. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunol Rev 2001, 181:126-137.
19. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003, 3:304-316.
20. Proteau M.F., Rousselle E., Makrigiannis A.P. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics 2004, 84:669-677.
21. Higuchi D.A., Cahan P., Gao J., Ferris S.T., Poursine-Laurent J., Graubert T.A., et al. Structural variation of the mouse natural killer gene complex. Genes Immun 2010, 11:637-648.
22. Scalzo A.A., Lyons P.A., Fitzgerald N.A., Forbes C.A., Shellam G.R. The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics 1995, 41:148-151.
23. Cheng T.P., French A.R., Plougastel B.F., Pingel J.T., Orihuela M.M., Buller M.L., et al. Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 2008, 60:565-573.
24. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997, 278:1623-1626.
25. Kim S., Iizuka K., Aguila H.L., Weissman I.L., Yokoyama W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A 2000, 97:2731-2736.
26. Lardenoye J.H., Delsing D.J., de Vries M.R., Deckers M.M., Princen H.M., Havekes L.M., et al. Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice. Circ Res 2000, 87:248-253.
27. Ewing M.M., de Vries M.R., Nordzell M., Pettersson K., de Boer H.C., van Zonneveld A.J., et al. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler Thromb Vasc Biol 2011, 31:95-101.
28. van Puijvelde G.H., van Wanrooij E.J., Hauer A.D., de Vos P., van Berkel T.J., Kuiper J. Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb Haemost 2009, 102:223-230.
29. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
30. Al-Lamee R., Ielasi A., Latib A., Godino C., Ferraro M., Arioli F., et al. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am J Cardiol 2010, 106:1721-1727.
31. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
32. Buzza M.S., Zamurs L., Sun J., Bird C.H., Smith A.I., Trapani J.A., et al. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J Biol Chem 2005, 280:23549-23558.
33. Schiller N.K., Boisvert W.A., Curtiss L.K. Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutations. Arterioscler Thromb Vasc Biol 2002, 22:1341-1346.
34. Hansson G.K., Hellstrand M., Rymo L., Rubbia L., Gabbiani G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989, 170:1595-1608.
35. McLaren J.E., Ramji D.P. Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009, 20:125-135.
36. Mitchell R.N., Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007, 100:967-978.
37. Taherzadeh Z., VanBavel E., de Vos J., Matlung H.L., van Montfrans G, Brewster L.M., et al. Strain-dependent susceptibility for hypertension in mice resides in the natural killer gene complex. Am J Physiol Heart Circ Physiol 2010, 298:H1273-H1282.